Regulation of 4‐1BB expression by cell‐cell interactions and the cytokines, interleukin‐2 and interleukin‐4

No abstract is available for this paper.

• Publication year

  1995

• Venue

  European Journal of Immunology

• Publication date

  1995-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/eji.1830250227PMID 7875212
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• 4‐1BB T‐cell antigen binds to mature B cells and macrophages, and costimulates anti‐μ‐primed splenic B cells

  1994cited by this paper
• Genomic organization and chromosomal localization of the T-cell antigen 4-1BB.

  1994cited by this paper
• The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death.

  1994cited by this paper
• Unraveling function in the TNF ligand and receptor families.

  1994cited by this paper
• Alloreactive cytotoxic T lymphocytes generated in the presence of viral-derived peptides show exquisite peptide and MHC specificity.

  1993cited by this paper
• Ligation of B7 with CD28/CTLA‐4 on T cells results in CD40 ligand expression, interleukin‐4 secretion and efficient help for antibody production by B cells

  1993cited by this paper
• B70 antigen is a second ligand for CTLA-4 and CD28

  1993cited by this paper
• Regulation of expression of the ligand for CD40 on T helper lymphocytes.

  1993cited by this paper
• Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal

  1993cited by this paper
• Inducible T cell antigen 4-1BB. Analysis of expression and function.

  1993cited by this paper
• A receptor induced by lymphocyte activation (ILA): a new member of the human nerve-growth-factor/tumor-necrosis-factor receptor family.

  1993cited by this paper
• Molecular cloning of a ligand for the inducible T cell gene 4‐1BB: a member of an emerging family of cytokines with homology to tumor necrosis factor

  1993cited by this paper
• CD30 is a signal-transducing molecule that defines a subset of human activated CD45RO+ T cells.

  1993cited by this paper
• The role of cell division in the induction of clonal anergy.

  1992cited by this paper
• T-cell activation molecule 4-1BB binds to extracellular matrix proteins.

  1992cited by this paper
• Identification and distribution of the costimulatory receptor CD28 in the mouse.

  1992cited by this paper
• Signalling through the MHC class II cytoplasmic domain is required for antigen presentation and induces B7 expression

  1992cited by this paper
• Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation

  1991cited by this paper
• IL-4 and IL-2 upregulate the expression of antigen B7, the B cell counterstructure to T cell CD28: an amplification mechanism for T-B cell interactions.

  1991cited by this paper
• IL-4 increases IL-2 production by T cells in response to accessory cell-independent stimuli.

  1991cited by this paper
• Role of the CD28 receptor in T-cell activation.

  1990cited by this paper
• A cell culture model for T lymphocyte clonal anergy.

  1990cited by this paper
• cDNA sequences of two inducible T-cell genes.

  1989cited by this paper
• A monoclonal antibody to murine CD45R distinguishes CD4 T cell populations that produce different cytokines

  1989cited by this paper
• Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway.

  1989cited by this paper
• Expression characteristics of two potential T cell mediator genes.

  1989cited by this paper
• CD28 activation pathway regulates the production of multiple T-cell-derived lymphokines/cytokines.

  1989cited by this paper

• Immunophenotypical characterization of immune checkpoint receptor expression in cynomolgus monkeys and human healthy volunteers in resting and in T-cell stimulatory conditions in vitro

  2025cites this paper
• Final results of urelumab, an anti-CD137 agonist monoclonal antibody, in combination with cetuximab or nivolumab in patients with advanced solid tumors

  2024cites this paper
• Cbl-b mitigates the responsiveness of naive CD8+ T cells that experience extensive tonic T cell receptor signaling

  2024cites this paper
• Accumulation of TCR signaling from self-antigens in naive CD8 T cells mitigates early responsiveness

  2023cites this paper
• Fcγ receptors and immunomodulatory antibodies in cancer

  2023cites this paper
• Rapid manufacturing of non-activated potent CAR T cells

  2022cites this paper
• Tumor-mediated 4-1BB induces tumor proliferation and metastasis in the colorectal cancer cells.

  2022cites this paper
• Boosting Antitumor Response by Costimulatory Strategies Driven to 4-1BB and OX40 T-cell Receptors

  2021cites this paper
• Functions of Immune Checkpoint Molecules Beyond Immune Evasion.

  2020cites this paper
• Immunology of Melanoma

  2020cites this paper
• Regulation of CD137 expression through K-Ras signaling in pancreatic cancer cells

  2019cites this paper
• Structure of the 4-1BB/4-1BBL complex and distinct binding and functional properties of utomilumab and urelumab

  2018cites this paper
• Structure of human 4-1BB / 4-1BBL complex

  2018cites this paper
• Modulating T Cell costimulation to prevent renal allograft rejection in nonhuman primates

  2017cites this paper
• 4-1BBL Enhances CD8+ T Cell Responses Induced by Vectored Vaccines in Mice but Fails to Improve Immunogenicity in Rhesus Macaques

  2014cites this paper
• The Role of TRAF1 in Signaling Downstream of 4-1BB on CD8 T Cells

  2013cites this paper
• CD137-selektierte leukämiereaktive T-Zellen gesunder Spender zur adoptiven Immuntherapie stammzelltransplantierter Leukämiepatienten

  2013cites this paper
• CD137 ligand signaling enhances myelopoiesis during infections

  2013cites this paper
• A high throughput method for enrichment of natural killer cells and lymphocytes and assessment of in vitro cytotoxicity.

  2013cites this paper
• Regulation of mouse 4-1BB expression: Multiple promoter usages and a splice variant

  2011cites this paper
• Adoptive T-cell Immunotherapy of Cancer Using Chimeric Antigen Receptor-Grafted T Cells

  2010cites this paper
• Co-signals in organ transplantation

  2010cites this paper
• The role of Mad4, Mnt and c-Myc proteins in OX40 stimulated T cells

  2009cites this paper
• Pancreatic lipase‐related protein 2 (PLRP2) induction by IL‐4 in cytotoxic T lymphocytes (CTLs) and reevaluation of the negative effects of its gene ablation on cytotoxicity

  2009influential citation
• Generierung und Charakterisierung von spezifischen T-Zell-Antworten gegen Pilz- und Tumorantigene

  2008cites this paper
• CD137 in the Regulation of T Cell Response to Antigen

  2006cites this paper
• Genes, Transcripts and Proteins of CD137 Receptor and Ligand

  2006cites this paper
• Immunotherapy Targeting 4-1BB and Its Ligand

  2006cites this paper
• Costimulation blockade and its possible future use in clinical transplantation

  2006cites this paper
• C-type lectin OCILRP2/Clr-g and its ligand NKRP1f costimulate T cell proliferation and IL-2 production.

  2005cites this paper
• CXCL16 and CD137 in atherosclerosis

  2005cites this paper
• [Regulation of immune response by T cell co-signaling. ].

  2005cites this paper
• Costimulatory Molecules in T CeII Activation and Transplantation

  2004cites this paper
• Costimulation of T cells by OX40, 4-1BB, and CD27.

  2003cites this paper
• NF‐κB and AP‐1 regulate activation‐dependent CD137 (4‐1BB) expression in T cells

  2003cites this paper
• Tumor Expression of 4-1BB Ligand Sustains Tumor Lytic T Cells

  2003cites this paper
• NF-kappaB and AP-1 regulate activation-dependent CD137 (4-1BB) expression in T cells.

  2003cites this paper
• Co-stimulatory members of the TNFR family: keys to effective T-cell immunity?

  2003cites this paper
• Induction of 4‐1BB (CD137) expression by DNA damaging agents in human T lymphocytes

  2002cites this paper
• In vivo stimulation of CD137 broadens primary antiviral CD8+ T cell responses

  2002cites this paper
• Cancer Gene Therapy: Past Achievements and Future Challenges

  2002cites this paper
• 4–1BB (CD137) controls the clonal expansion and survival of CD8 T cells in vivo but does not contribute to the development of cytotoxicity

  2002cites this paper
• 4-1BB Ligand Induces Cell Division, Sustains Survival, and Enhances Effector Function of CD4 and CD8 T Cells with Similar Efficacy1

  2001cites this paper
• Phenotypic Characterization of Subsets of T Cell Lymphoma: Towards a Functional Classification of T Cell Lymphoma

  2001cites this paper
• CD4 and CD8 T Cells with Similar Efficacy Survival, and Enhances Effector Function of 4-1BB Ligand Induces Cell Division, Sustains

  2001cites this paper
• A novel leucine-rich repeat protein (LRR-1): potential involvement in 4-1BB-mediated signal transduction.

  2001cites this paper
• Divergent effects of 4-1BB antibodies on antitumor immunity and on tumor-reactive T-cell generation.

  2001cites this paper
• Modulation of the immune response through 4-1BB.

  2000cites this paper
• Activation of c-jun N-terminal kinase by 4-1BB (CD137), a T cell co-stimulatory molecule.

  2000cites this paper
• A Humanized Anti–4-1BB Monoclonal Antibody Suppresses Antigen-Induced Humoral Immune Response in Nonhuman Primates

  2000cites this paper
• Co‐stimulation of antigen‐specific CD4 T cells by 4‐1BB ligand

  2000cites this paper
• 4-1BB: Still in the Midst of Darkness

  2000cites this paper
• Enhanced Therapeutic Potential of Adoptive Immunotherapy by In Vitro CD28/4-1BB Costimulation of Tumor-Reactive T Cells Against a Poorly Immunogenic, Major Histocompatibility Complex Class I-Negative A9P Melanoma

  2000cites this paper
• Relative abilities of 4-1BB (CD137) and CD28 to co-stimulate the response of cytokine deflected Th1 and Th2 cells.

  1999cites this paper
• Differential expression and costimulatory effect of 4-1BB (CD137) and CD28 molecules on cytokine-induced murine CD8(+) Tc1 and Tc2 cells.

  1999cites this paper
• Human 4‐1BB regulates CD28 co‐stimulation to promote Th1 cell responses

  1998cites this paper
• Overcoming T cell ignorance by providing costimulation. Implications for the immune response against cancer.

  1998cites this paper
• Tumor necrosis factor receptor family members in the immune system.

  1998cites this paper
• T cell immunity to tumor antigens.

  1998cites this paper
• Overcoming T Cell Ignorance by Providing Costimulation

  1998cites this paper
• Glucocorticoids: regulation of gene expression and apoptosis.

  1998cites this paper
• Handbook of Imune Response Genes

  1998cites this paper
• Ox-40 ligand: a potent costimulatory molecule for sustaining primary CD4 T cell responses.

  1998cites this paper
• Amplification of tumor immunity by gene transfer of the co‐stimulatory 4‐1BB ligand: synergy with the CD28 co‐stimulatory pathway

  1998cites this paper
• Molecule for Sustaining Primary CD 4 T Cell Ox-40 Ligand : A Potent Costimulatory

  1998cites this paper
• Antibodies to TR2 (herpesvirus entry mediator), a new member of the TNF receptor superfamily, block T cell proliferation, expression of activation markers, and production of cytokines.

  1998cites this paper
• Strong expression of CD134 (OX40), a member of the TNF receptor family, in a T helper 2‐type cytokine environment

  1998cites this paper
• A new member of the tumor necrosis factor/nerve growth factor receptor family inhibits T cell receptor-induced apoptosis.

  1997cites this paper
• Analysis of 4-1BBL and Laminin Binding to Murine 4-1BB, a Member of the Tumor Necrosis Factor Receptor Superfamily, and Comparison with Human 4-1BB*

  1997cites this paper
• Signals through 4-1BB are costimulatory to previously activated splenic T cells and inhibit activation-induced cell death.

  1997cites this paper
• Accessory molecule and costimulation requirements for CD4 T cell response.

  1997cites this paper
• Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors

  1997cites this paper
• Molecular, structural, and biological characteristics of the tumor necrosis factor ligand superfamily

  1996cites this paper
• 4-1BB is expressed on CD45RAhiROhi transitional T cell in humans.

  1996cites this paper
• Potential role of 4-1BB in T cell activation. Comparison with the costimulatory molecule CD28.

  1995cites this paper
• The TNF ligand superfamily and its relevance for human diseases.

  1995cites this paper
• Expression of CD 137 and CD 137 ligand in colorectal cancer patients

  year unknowncites this paper